D-0391-2024 Class II Ongoing
FDA drug recall D-0391-2024 was initiated by Eugia US LLC on Feb 20, 2024 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: Out of specification for organic impurities The recall status is ongoing. Affected quantity: 43,920 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 27, 2024
- Initiation Date
- Feb 20, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 43,920 vials
Product description
Nicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) 10 mL vials, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, NDC 55150-183-11
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification for organic impurities
Distribution pattern
Nationwide within the United States
Code information
Lot #: 3NC22019, Exp. Date 2/24
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0391-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026